picolinamide has been researched along with Angiogenesis, Pathologic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cao, ZX; Lin, HJ; Luo, SD; Mao, YQ; Wang, Z; Wei, YQ; Xu, YZ; Yang, L; Yang, SY; Yu, LT; Zeng, XX; Zhao, YL; Zheng, RL; Zhou, LN; Zhou, Y | 1 |
1 other study(ies) available for picolinamide and Angiogenesis, Pathologic
Article | Year |
---|---|
SKLB610: a novel potential inhibitor of vascular endothelial growth factor receptor tyrosine kinases inhibits angiogenesis and tumor growth in vivo.
Topics: Amides; Angiogenesis Inhibitors; Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Collagen; Colorectal Neoplasms; Drug Combinations; Endothelial Cells; Female; Humans; Laminin; Mice; Mice, Nude; Mitogen-Activated Protein Kinase 1; Neovascularization, Pathologic; Phosphorylation; Picolinic Acids; Protein Kinase Inhibitors; Proteoglycans; Receptor, Fibroblast Growth Factor, Type 2; Receptors, Platelet-Derived Growth Factor; Umbilical Veins; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays; Zebrafish | 2011 |